Coronary artery vasculitis and encasement
Conditions
Interventions
Observation group:None
Sponsors
Beijing Anzhen Hospital, Capital Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Diagnosis of systemic diseases (such as Takayasu's arteritis, giant cell arteritis, Kawasaki disease, ANCA-associated arteritis, HIV-associated vasculitis, IgG4-related diseases, histiocytosis, amyloidosis, sarcoma, angiosarcoma, lymphoma or metastases); 2. Complete coronary CTA examination within 30 days before receiving hormones, immunosuppressants or anti-rheumatic drugs or interventional therapy; 3. Signed written informed consent.
Exclusion criteria
Exclusion criteria: 1. CTA images cannot be obtained, or the quality is poor; 2. Uncontrolled infectious diseases; 3. Subjects have participated in other clinical trials in the past 3 months; 4. Pregnant or lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Perivascular adipose tissue attenuation; | — |
Secondary
| Measure | Time frame |
|---|---|
| Coronary artery diameter stenosis;Coronary artery stenosis location;Coronary artery wall thickness;Coronary artery aneurysm; | — |
Countries
China
Contacts
Public ContactYu Du
Beijing Anzhen Hospital, Capital Medical University
Outcome results
None listed